These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6141052)

  • 1. Bioavailability of drugs with long elimination half-lives.
    Urso R; Aarons L
    Eur J Clin Pharmacol; 1983; 25(5):689-93. PubMed ID: 6141052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
    Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
    PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Hill's equation for estimating area under the concentration-time curve (AUC) and use of time to AUC 90% for expressing kinetics of drug disposition.
    Cheng HC
    J Pharmacol Toxicol Methods; 2009; 60(3):296-300. PubMed ID: 19439184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of oral bioavailability of a long half-life drug in healthy subjects.
    Sharma A; Slugg PH; Hammett JL; Jusko WJ
    Pharm Res; 1998 Nov; 15(11):1782-6. PubMed ID: 9834003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food intake and drug bioavailability.
    Melander A
    Prog Clin Biol Res; 1981; 77():747-56. PubMed ID: 6121332
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect.
    Tubic M; Wagner D; Spahn-Langguth H; Bolger MB; Langguth P
    Pharm Res; 2006 Aug; 23(8):1712-20. PubMed ID: 16832615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility of the in vitro evaluation of bioavailability. 3: Method of operation of a newly-developed absorption model and results obtained with it].
    Fürst W; Neubert R; Stütz B; Fuchs G; Buchmann E
    Pharmazie; 1982 Aug; 37(8):571-7. PubMed ID: 7146065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of absorption ratios and their variation for orally administered drugs.
    Betzien G; Kaufmann B; Schneider B
    Eur J Clin Pharmacol; 1982; 22(3):265-72. PubMed ID: 7106160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of drugs in the elderly.
    Lee EJ
    Ann Acad Med Singap; 1987 Jan; 16(1):128-32. PubMed ID: 2884923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a novel method to estimate absolute bioavailability of drugs from oral data.
    Hinderling PH
    Biopharm Drug Dispos; 2003 Jan; 24(1):1-16. PubMed ID: 12516074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid methods for bioavailability determination utilizing urinary excretion data.
    Niebergall PJ; Sugita ET; Schnaare RL
    J Pharm Sci; 1975 Oct; 64(10):1721-2. PubMed ID: 1185547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.